Geriatrics

Denmark study finds no increased risk of 28 adverse events following vaccination with a monovalent XBB.1.5-containing vaccine given as a fifth dose to adults 65 years or older.

Study suggests associations may be weak, but still worth encouraging activity.

The European iSIMPATHY project proves the value of a seven steps approach to medication reviews, enabling pharmacists to manage polypharmacy.

The more fibre, the better the effect.

First Canadian guidelines for anxiety in older adults are now available to help support healthcare providers with assessment and treatment.

By 2050, almost one out of every four people who develop dementia in Canada will be of Asian origin, a 785% increase from 2020.

Study evaluates efficacy of one and two doses of recombinant zoster vaccine overall, by time since vaccination, age and immunocompromise status, and with a late second dose.

A McGill study suggests more specific guidance is needed on nutrition for certain subgroups of the population.